News

Bioanalytical fit-for-purpose solutions for preclinical and clinical development Biomarkers and PK/PD studies play key roles in the drug development process with the potential to improve the success r...

In this interview, Emmanuel Vincent, co-founder and CEO of Aenitis Technologies, and Dr. Michel Angue, Chief Business Development Officer of Aenitis Technologies, tell us about the acoustophoresis tec...

A new high-throughput tool for smaller sample volumes The MBeads Assay enables a broader measuring range with the lowest sample volume. Use MBeads to reach the same specificity as our high-performance...

The secretion of many gastrointestinal hormones is known to be altered after bariatric surgery and as one of the proglucagon-derived proteins, glicentin has recently been given new possibilities to be...

Oxidized low-density lipoprotein (oxidized LDL) is an established biomarker for oxidative stress and a specific causal biomarker for the atherosclerotic disease process. Elevated plasma levels of oxid...

Mercodia offers products and services with well-defined quality and high precision of delivery which places the utmost importance on our Quality Department and the role they play within Mercodia. Meet...

Mercodia Assay Quality System, MAQS, is a 69-point program developed to explore and explain the unrivaled quality of our products and is the first certification of its kind. Your research projects and...

In this interview Professor Rémy Burcelin, Head of Research Inserm, tells his story about the search for sensitive insulin, glucagon and GLP-1 markers. Prof. Rémy Burcelin and his team aims at identif...

Jörgen Dahlström joined Mercodia as new CEO as of the 1st of October of 2021. We spoke to him about his background in life science, but more importantly about his desire to drive Mercodia forward. Jör...